# Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience

> **NCT07231796** · — · RECRUITING · sponsor: **Professor Monique A. H. Steegers** · enrollment: 100 (estimated)

## Conditions studied

- Cancer
- Opioid Induced Constipation (OIC)

## Interventions

- **DRUG:** Naldemedine, an peripherally acting opioid antagonist

## Key facts

- **NCT ID:** NCT07231796
- **Lead sponsor:** Professor Monique A. H. Steegers
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-02
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-03-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07231796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07231796, "Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07231796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*